Literature DB >> 26400157

Axillary Ultrasound in the Management of the Newly Diagnosed Breast Cancer Patient.

Zahraa Al-Hilli1, Tina J Hieken1, Judy C Boughey1.   

Abstract

Axillary lymph node status remains an important prognostic factor in patients with breast cancer. Axillary ultrasound (AUS) is an important tool in the workup of patients with newly diagnosed breast cancer and also has an emerging role evaluating the axilla after neoadjuvant chemotherapy. This review discusses the value of AUS in the workup and management of patients with newly diagnosed breast cancer and describes its role given the recent changes in axillary management.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  axillary ultrasound; breast cancer; sentinel lymph node

Mesh：

Year:  2015        PMID： 26400157     DOI： 10.1111/tbj.12497

Source DB:  PubMed          Journal:  Breast J        ISSN： 1075-122X            Impact factor:   2.431


  4 in total

1.  Accuracy of axillary ultrasound after different neoadjuvant chemotherapy cycles in breast cancer patients.

Authors:  Bei-Bei Ye; Hong-Meng Zhao; Yue Yu; Jie Ge; Xin Wang; Xu-Chen Cao
Journal:  Oncotarget       Date:  2017-05-30

2.  Phase-Transition Nanodroplets for Real-Time Photoacoustic/Ultrasound Dual-Modality Imaging and Photothermal Therapy of Sentinel Lymph Node in Breast Cancer.

Authors:  Lu Yang; Juan Cheng; Yuli Chen; Shengjie Yu; Fengqiu Liu; Yang Sun; Yu Chen; Haitao Ran
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

3.  Application of the Machine-Learning Model to Improve Prediction of Non-Sentinel Lymph Node Metastasis Status Among Breast Cancer Patients.

Authors:  Qian Wu; Li Deng; Ying Jiang; Hongwei Zhang
Journal:  Front Surg       Date:  2022-04-25

4.  Management of the axilla in metaplastic breast carcinoma.

Authors:  Brittany L Murphy; Robert T Fazzio; Tanya L Hoskin; Katrina N Glazebrook; Michael G Keeney; Elizabeth B Habermann; Tina J Hieken
Journal:  Gland Surg       Date:  2018-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.